RAKEL
LOPEZ DE MATURANA GARMENDIA
Investigador/a en el periodo 2005-2014
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
Madrid, EspañaPublicaciones en colaboración con investigadoras/es de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (7)
2018
-
iPS Cell Cultures from a Gerstmann-Sträussler-Scheinker Patient with the Y218N PRNP Mutation Recapitulate tau Pathology
Molecular Neurobiology, Vol. 55, Núm. 4, pp. 3033-3048
2016
-
Mutations in LRRK2 impair NF-ΚB pathway in iPSC-derived neurons
Journal of Neuroinflammation, Vol. 13, Núm. 1
2014
-
Sustained Increase of PKA Activity in the Postcommissural Putamen of Dyskinetic Monkeys
Molecular Neurobiology, Vol. 50, Núm. 3, pp. 1131-1141
2013
-
The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway
Cellular and Molecular Life Sciences, Vol. 70, Núm. 1, pp. 121-136
2012
-
The MAPK1/3 pathway is essential for the deregulation of autophagy observed in G2019S LRRK2 mutant fibroblasts
Autophagy, Vol. 8, Núm. 10, pp. 1537-1539
2009
-
Early changes in hippocampal eph receptors precede the onset of memory decline in mouse models of alzheimer's disease
Journal of Alzheimer's Disease, Vol. 17, Núm. 4, pp. 773-786
-
Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Aβ levels
Neurobiology of Disease, Vol. 33, Núm. 3, pp. 369-378